Hosted in Boston in collaboration with the British Consulate, this event highlights groundbreaking strategies and partnerships accelerating healthcare advancements. Our team will discuss initiatives focusing on innovative treatment pathways and technological breakthroughs. From AI-driven diagnostics to next-generation therapies, the topics are designed to inspire transformative collaborations. Reach out to schedule a discussion with us and explore how our expertise aligns with your goals in innovation.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
